Vevye®

DRUG2 trials

Sponsors

Hoffmann-La Roche, Baylor College of Medicine

Conditions

Dry Eye DiseaseDry Eye Disease (DED)

Phase 4

A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment

CompletedNCT07025811

Hoffmann-La RocheDry Eye Disease

Start: 2025-07-09End: 2026-07-16Updated: 2026-07-27

Comparison of Conjunctival Goblet Cell Density in Dry Eye Patients Treated With Cyclosporine 0.1% Dissolved in Perfluorobutylpentane (Vevye®) or Generic 0.05% Cyclosporine Emulsion for 8 Weeks

Not yet recruitingNCT07368595

Baylor College of MedicineDry Eye Disease (DED)

Start: 2026-09-01End: 2027-06-01Target: 60Updated: 2026-06-03